Brickwork Ratings assigns the ratings for the Bank Loan Facilities of Rs. 59.79 Crs. of North East Healthcare Pvt. Ltd.
Particulars| Facilities** | Amount(Rs.Crs.) | Tenure | Rating# | |
|---|---|---|---|---|
| Fund Based | 59.79 | Long Term |
BWR BBB -
/Stable Assignment |
|
| Grand Total | 59.79 | (Rupees Fifty Nine Crores and Seventy Nine lakhs Only) | ||
Brickwork Ratings has assigned ratings of BWR BBB- with a Stable outlook to the long term bank loans of Rs. 59.79 Crs of North East Healthcare Pvt. Ltd (NEHPL or the Company).The rating reflects the extensive experience of over three decades of the Promoters’ of NEHPL’s in the healthcare industry,as they have been running four hospitals under the Pratiksha group, including one in Uzbekistan and three in India, for a considerable period. The hospital also benefits from the established market position of NEHPL being a NABH and NABL accredited multispeciality hospital having 20 medical departments offering various critical medical services, as well as it's improving financial and credit risk profile with the hospital achieving breakeven in FY22 on the back of a sequential increase in bed occupancies to 60% in FY22. The ratings also take cognizance of its adequate liquidity position along with the expected improvement in NEHPL's financial risk profile with the completion of the ongoing expansions of the installed bed capacities by 100 beds as well as receipt of license and approvals for kidney transplant and cardiac surgeries which is likely to trigger higher OPD footfalls and IPD admissions going forward. The ratings are however constrained by NEHPL's exposure to intense competition, regulatory risks as well as the risk arising out of the ongoing debt-led CAPEX which shall add to the Hospital's gearing levels and increase its debt obligations. Timely completion of the expansion and ramp-up of bed occupancy will be the key monitorables going forward.
Brickwork Ratings believes that the business profile of North East Healthcare Pvt Ltd. will be maintained over the medium term. The “Stable ” Outlook factors in the increase in the scale of operations and average revenue per occupied bed along with stable margins and improved cash flows resulting in an improved financial risk profile. The rating outlook may be revised to Positive in case the revenues and profitability surpass the projected levels meaningfully. The rating outlook may be revised to Negative if the revenues go down and margins show lower than expected figures.
BWR has essentially relied upon NEHPL's audited financials upto FY22, brief provisional financials for April 2022-August 2022 and projected financial statements from FY23 to FY26, publicly available information and information/clarifications provided by the Hospital’s management, and their bankers.
Credit Strengths:
NEHPL's management is professionally skilled and has extensive experience in the medical industry. Dr. Pramod Kumar Sharma, Chairman and Managing Director of the hospital is a renowned Gynecologist and has about three decades of experience in the medical profession in India. He specializes in IVF treatment. The hospital also has an experienced team of doctors and executives in managing the day-to-day affairs. Dr. Rajesh Kumar Verma, Director-orthopaedics has over two decades of experience in Orthopedics and specialises in spine surgery. Dr. Hemant Sharma, another renowned orthopedist has a total experience of over 15 years and also specialises in spine surgery. He has been associated with the hospital for the last 6 years.
The W Pratiksha hospital run under NEHPL is a multi-specialty hospital catering to patients in Gurgoan and surrounding regions. The 110 bedded hospital is accredited by the National Accreditation Board for Hospitals and Healthcare providers (NABH) and National Accreditation Board for Testing & Calibration (NABL). The accredited hospital has about 20 medical services departments including Orthopedics, Cardiology, Internal medicine and diabetology,Neurosurgery,Pulmonology, Urology, Gastroenterology, Clinical Oncology, etc. Orthopedics and related surgeries continue to be its forte, accounting for nearly about 30% of the total income. The hospital is focussing on high-end surgeries. It has recently obtained licenses for kidney transplants and cardiac surgeries. This is likely to trigger higher OPD footfalls and IPD admissions leading to an improvement in bed occupancies and high end surgeries, going forward.
The hospital attracts international patients particularly from Iraq and Afghanistan through referrals from the international arm of the Group-Zarmed Pratiksha in Samarkand, Uzbekistan, which is a multi-speciality hospital in the Country with departments like Gynaecology, Paediatrics, Gastroenterology, Urology, Nephrology and others. NEHPL also has channel partners in Afghanistan and Iraq as well as tie ups with the Ministries and government bodies that sponsor their patients for surgeries. In the same region, the Company had in the past tied up with the Red Cross for speciality surgeries. The hospital’s doctors also frequently visit Uzbekistan for surgeries and consultations which help direct patients from the location to NEHPL.
The hospital reported a 30% y-o-y jump in topline to Rs.85Crs in FY22 on bed occupancies of 60%, up from 55% in FY21. Total OPD footfall has increased by 18.28% in FY22 to 33970 after a 36% fall in footfalls in FY21 owing to the pandemic. IP admissions have increased by 27% y-o-y to 5889 in FY22 from 4625 in FY21. The Company expects footfalls and IP admissions to increase further in FY23 on the back of expected higher bed occupancies and high end surgeries with license and approvals received for kidney transplants and Cardiac surgeries. Average revenue per bed improved to Rs.41206 in FY22 from Rs.35949 in FY21. EBIDTA improved to Rs15.65Crs in FY22 from Rs.8.18Crs in FY21 while the hospital achieved breakeven and reported net profits of Rs.8.97Crs in FY22 as against a net loss of Rs.0.61Crs in FY21. PAT is expected to moderate slightly going forward due to higher depreciation charges on the back of the Capex. Debt protection metrics continue to remain acceptable. ISCR has improved to 3.32x in FY22 from 1.45x in FY21 and DSCR improved to 1.12x in FY22 from its historically low levels with improved profitability. Total borrowings reduced in FY22 to Rs.58.4Crs. from Rs.74.5Crs in FY21 with repayment of term loans and unsecured loans. However, debt is likely to increase in FY23 on account of drawdown of Term Loans which are being proposed. Net worth is negative due to past losses (which is characteristic of new entities in this sector) as well as adjustment of revaluation reserves. However, net worth is expected to turn positive as the hospital has reported net profitability in FY22 and consistent accretion to reserves is expected to strengthen the capital structure.
The hospital is ramping up its bed capacities by adding 100 beds to its existing bed capacities by building two additional floors at the same premises. The total number of beds will increase to 210 beds from 110 beds currently post expansions which are expected to be completed and become fully operational by FY24. By FY25, the hospital expects to run at bed occupancies of 75% to 80%.
NEHPL faces competition from well-established multi-specialty hospitals in the region. Further, the company’s income depends on a single hospital unit located in Gurgoan which exposes it to greater risk.
The hospital industry is government regulated. Apart from licensing and approvals, the Government has also capped prices of drugs and consumables as well as medical processes including medical devices such as coronary and knee implants which has impacted the topline and margins of the players in the industry.
The hospital has an ongoing debt-led CAPEX at a cost of Rs.17Crs. The hospital intends to fund ~75% of the total CAPEX with bank loans which will add to its gearing levels and debt service obligations. Successful and timely completion of the CAPEX, functioning of the new capacities as well as sustained gearing levels and debt coverage ratios will be the key monitorable going forward.
BWR has applied its rating methodology as detailed in the Rating Criteria (hyperlinks provided at the end of this rationale)
RATING SENSITIVITIES
Positive:
Negative:
NEHPL's liquidity is adequate. Average bank limit utilization for the last 12 months has remained low. Expected net cash accruals of ~Rs.15 Crs is expected to remain sufficient against repayment obligations of around Rs.11.6Crs in FY23 (including repayments of unsecured loans which depends on the funds availability). Estimated moderate cash and bank balance provides additional support to liquidity. Current ratio is estimated to be moderate at around 1.5 times as on 31 March, 2023.
North East Healthcare Private Limited (NEHPL) was incorporated on 28 June 2010 with registered office in Guwahati, Assam. The Company owns and runs W Pratiksha Hospital located in Gurgoan. W Pratiksha hospital is the flagship hospital of the Pratiksha Group of North East and is a premier multispecialty hospital that commenced operations in 2015 with an initial capacity of 110 beds in Gurgoan. It offers services in Obstetrics & Gynaecology, Pediatrics & Neonatology, IVF & Fertility, Critical Care, ICU& NICU, Cardiology, Orthopaedics & Spine Surgery, GI Bariatric & Minimal Access Surgery, Neurology & Dialysis, Neuro Surgery, Urology & Andrology, Nephrology, Gastroentrology& Hepatology, Plastic Surgery, Nutrition &Dietitics, Internal Medicine, Pulmonology,Medical Oncology & Cancer Care with Chemo Day Care,ENT, Opthalmology, Physiotherapy & Rehabilitation, Clinical Psychology, Dermatology, Audiology and Speech Therapy and Emergency. The hospital has a cafeteria, wellness lounges, an OPD area and premium lounges for international patients. In 2019, the hospital was accredited by - National Accreditation Board for Hospitals & Healthcare providers and National Accreditation Board for Testing & Calibration.
NEHPL is a part of the Northeast based- Pratiksha Group which runs four hospitals including 2 in the Northeast, 1 in Gurgaon, and 1 in Uzbekistan under the group companies as mentioned below-
| Key Parameters | Units |
FY 21-22 (Audited) |
FY 20-21 (Audited) |
|---|---|---|---|
| Operating Revenue | Rs.Crs. | 85.26 | 65.44 |
| EBITDA | Rs.Crs. | 15.65 | 8.18 |
| PAT | Rs.Crs. | 8.97 | -0.61 |
| Tangible Net Worth | Rs.Crs. | -9.56 | -18.56 |
| Total Debt/TNW | Times | -6.11 | -4.01 |
| Current Ratio | Times | 0.72 | 1.27 |
The terms of sanction include standard covenants normally stipulated for such facilities.
NA.
RATING HISTORY FOR LAST THREE YEARS (including withdrawal and suspended)| Facilities | Current Rating (2022) | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Type | Tenure | Amount (Rs.Crs.) |
Rating | Date | Rating | Date | Rating | Date | Rating |
| Fund Based | LT | 59.79 |
BWR BBB-/Stable
(Assignment) |
NA |
NA
|
NA |
NA
|
NA |
NA
|
| Grand Total | 59.79 | (Rupees Fifty Nine Crores and Seventy Nine lakhs Only) | |||||||
BWR complexity levels are meant for educating investors. The BWR complexity levels are available at www.brickworkratings.com / download / ComplexityLevels.pdf. Investors queries can be sent to info@brickworkratings.com.
Hyperlink/Reference to applicable Criteria| Analytical Contacts | |
|---|---|
|
Madhu Sonthalia Senior Rating Analyst Board : +91 80 4040 9940 madhusonthalia@brickworkratings.com |
Anuradha Gupta Director - Ratings anuradha.g@brickworkratings.com |
| 1-860-425-2742 | media@brickworkratings.com | |
| SL.No. | Name of the Bank/Lender | Type Of Facilities | Long Term(Rs.Crs.) | Short Term(Rs.Crs.) | Total(Rs.Crs.) | |
|---|---|---|---|---|---|---|
| 1 | HDFC Bank | Term LoanSanctioned | 40.19 | _ | 40.19 | |
| 2 | HDFC Bank | Term LoanProposed | 10.00 | _ | 10.00 | |
| 3 | HDFC Bank | Over DraftProposed | 3.00 | _ | 3.00 | |
| 4 | HDFC Bank | Dropline ODSanctioned | 2.00 | _ | 2.00 | |
| 5 | HDFC Bank | GECLSanctioned | 4.60 | _ | 4.60 | |
| Total | 59.79 | 0.00 | 59.79 | |||
| TOTAL (Rupees Fifty Nine Crores and Seventy Nine lakhs Only) | ||||||
The Rating Rationale is sent to you for the sole purpose of dissemination through your print, digital or electronic media. While it may be used by you acknowledging credit to BWR, please do not change the wordings in the rationale to avoid conveying a meaning different from what was intended by BWR. BWR alone has the sole right of sharing (both direct and indirect) its rationales for consideration or otherwise through any print or electronic or digital media.
About Brickwork RatingsBrickwork Ratings (BWR), a Securities and Exchange Board of India [SEBI] registered Credit Rating Agency and accredited by Reserve Bank of India [RBI], offers credit ratings of Bank Loan, Non- convertible / convertible / partially convertible debentures and other capital market instruments and bonds, Commercial Paper, perpetual bonds, asset-backed and mortgage-backed securities, partial guarantees and other structured / credit enhanced debt instruments, Security Receipts, Securitization Products, Municipal Bonds, etc. BWR has rated over 12,000 medium and large corporates and financial institutions’ instruments. BWR has also rated NGOs, Educational Institutions, Hospitals, Real Estate Developers, Urban Local Bodies and Municipal Corporations. BWR has Canara Bank, a leading public sector bank, as one of the promoters and strategic partner. BWR has its corporate office in Bengaluru and a country-wide presence with its offices in Ahmedabad, Chandigarh, Chennai, Hyderabad, Kolkata, Mumbai and New Delhi along with representatives in 150+ locations.
Disclaimer
Brickwork Ratings India Pvt. Ltd. (BWR), a Securities and Exchange Board of India [SEBI] registered Credit Rating Agency and accredited by the Reserve Bank of India [RBI], offers credit ratings of Bank Loan facilities, Non- convertible / convertible / partially convertible debentures and other capital market instruments and bonds, Commercial Paper, perpetual bonds, asset-backed and mortgage-backed securities, partial guarantees and other structured / credit enhanced debt instruments, Security Receipts, Securitization Products, Municipal Bonds, etc. [ hereafter referred to as "Instruments"]. BWR also rates NGOs, Educational Institutions, Hospitals, Real Estate Developers, Urban Local Bodies and Municipal Corporations.
BWR wishes to inform all persons who may come across Rating Rationales and Rating Reports provided by BWR that the ratings assigned by BWR are based on information obtained from the issuer of the instrument and other reliable sources, which in BWR's best judgment are considered reliable. The Rating Rationale / Rating Report & other rating communications are intended for the jurisdiction of India only. The reports should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in Europe and also the USA).
BWR also wishes to inform that access or use of the said documents does not create a client relationship between the user and BWR.
The ratings assigned by BWR are only an expression of BWR's opinion on the entity / instrument and should not in any manner be construed as being a recommendation to either, purchase, hold or sell the instrument.
BWR also wishes to abundantly clarify that these ratings are not to be considered as an investment advice in any jurisdiction nor are they to be used as a basis for or as an alternative to independent financial advice and judgment obtained from the user's financial advisors. BWR shall not be liable to any losses incurred by the users of these Rating Rationales, Rating Reports or its contents. BWR reserves the right to vary, modify, suspend or withdraw the ratings at any time without assigning reasons for the same.
BWR's ratings reflect BWR's opinion on the day the ratings are published and are not reflective of factual circumstances that may have arisen on a later date. BWR is not obliged to update its opinion based on any public notification, in any form or format although BWR may disseminate its opinion and analysis when deemed fit.
Neither BWR nor its affiliates, third party providers, as well as the directors, officers, shareholders, employees or agents (collectively, "BWR Party") guarantee the accuracy, completeness or adequacy of the Ratings, and no BWR Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Rating Rationales or Rating Reports. Each BWR Party disclaims all express or implied warranties, including, but not limited to, any warranties of merchantability, suitability or fitness for a particular purpose or use. In no event shall any BWR Party be liable to any one for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Rating Rationales and/or Rating Reports even if advised of the possibility of such damages. However, BWR or its associates may have other commercial transactions with the company/entity. BWR and its affiliates do not act as a fiduciary.
BWR keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of BWR may have information that is not available to other BWR business units. BWR has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.
BWR clarifies that it may have been paid a fee by the issuers or underwriters of the instruments, facilities, securities etc., or from obligors. BWR's public ratings and analysis are made available on its web site, www.brickworkratings.com. More detailed information may be provided for a fee. BWR's rating criteria are also generally made available without charge on BWR's website.
This disclaimer forms an integral part of the Ratings Rationales / Rating Reports or other press releases, advisories, communications issued by BWR and circulation of the ratings without this disclaimer is prohibited.
BWR is bound by the Code of Conduct for Credit Rating Agencies issued by the Securities and Exchange Board of India and is governed by the applicable regulations issued by the Securities and Exchange Board of India as amended from time to time.